PDT Laser Systems (ML6710i & ML7710)
Advanced Photodynamic Therapy Solutions for Oncology, Ophthalmology & Clinical Research
PDT lasers play a vital role in Photodynamic Therapy (PDT) — a minimally invasive treatment that uses light-activated drugs (photosensitizers) and precise laser wavelengths to selectively destroy abnormal cells. Widely adopted in oncology and ophthalmology, PDT enables targeted therapy with fewer side effects, making it a preferred choice for treating cancerous and retinal conditions.
Ophthalmic PDT
The Modulight ML6710i is a validated medical laser device. This PDT laser system is designed for ophthalmic treatments, especially Retinal Therapies. ML6710i ensures accurate and reliable light delivery for Ophthalmic PDT — an established laser-based treatment that activates a photosensitive drug in the retina.
The laser is controlled intuitively and esily with an iPad app — the wireless connection allows flexibility for the treatment setup. ML6710i is connected to Modulight Cloud, which enables safe storing of treatment logs, while not exposing patient data.
The standard wavelength of the ML6710i is 689 nm matching the Verteporfin absorption. As Modulight has the capability to tailor its solutions, we can generally support all wavelengths from UV to 3000+ nm — just ask us about the tailored solutions.
PDT in Oncology
Modulight ML7710 is a multi-indication and multichannel laser platform designed for demanding medical environments. Engineered for both clinical and research applications, ML7710’s cloud-connectivity and intuitive user interface make it suitable for various medical applications, ranging from photoimmunotherapy (PIT), photodynamic therapy (PDT) to fluorescence imaging and photothermal therapy.
With laser activation by ML7710, cancer cells are destroyed whilst the immune system is stimulated. ML7710 supports all photosensitive substances/molecules including 5-ALA, Gliolan/Levulan, Metvix, Visudyne, Photofrin, Amphinex, Pc4, Methylene blue, Fluorescein, ICG, Tookad, Foscan, Fotolon, Radachlorin, IRDye 700 (all are trademarks of respective owners) and many others in the wavelength range of UV to 3000+ nm.
Designed for Professional Use in PDT Laser Therapy
Ophthalmology
Trusted by leading eye clinics for PDT laser treatment*) of the retina, including CSR, wet AMD, and polypoidal choroidal vasculopathy (PCV). The ML6710i system supports precise targeting and integration with slit lamps and ophthalmic treatment setups.
Key Features of the ML6710i PDT Laser
- Clinically approved 689 nm PDT laser, optimized for Verteporfin
- Portable, smart-device-controlled system with Modulight Cloud connectivity
- Uniform light delivery with adjustable spot size and power settings
- Easily integrated with slit lamp and ophthalmic treatment station
- Automatic treatment log to support analytics and regulatory compliance
Typical Applications
- PDT for retinal disorders such as CSR, AMD, and PCV *)
- PDT in Ocular Oncology for choroidal/uveal melanoma targeted therapy
- Tailored solutions for Novel Ophthalmic Indications in medical devices
*) See references to scientific publications about Central Serous Retinopathy (CSR), Age-related Macular Degeneration (AMD), and other retinal indications here.
Oncology
Modulight’s ML7710 supports all commercially available and novel photosensitizers, including ALA, Temoporfin, Talaporfin, Verteporfin, and Padeliporfin.
ML7710 is ideal for tumor-targeted ALA-PDT treatments, as well as clinical research. Modulight systems are used globally in both clinical trials and hospital settings, and the ML7710 offers unmatched performance, safety, and precision.
Key Features of the ML7710 Multi-Indication Laser
- Clinically validated Multi-Indication Laser Platform, optimized for Photoimmunotherapy (PIT) and Photodynamic Therapy (PDT) treatments
- Connected to Modulight Cloud — key feature for improving the treatment efficacy based on the real-time data analysis
- ML7710 supports tailorerd light delivery options: frontal or cylindrical diffuser fibers, balloon illuminator, or endoscopic interface
Typical Applications
- Glioblastoma interstitial treatments with 5-ALA (5-aminolevulinic acid) with PpIX fluorescence monitoring
- Cystoscopic photoimmunotherapy for non-muscle invasive bladder cancer (NMIBC) tumors
- Targeted PIT/PDT for superficial and deep tumors: head & neck, esophageal, and skin cancers
Why Choose Modulight?
With over 20 years of experience in medical-grade laser systems, Modulight serves hospitals, research institutes, and medtech companies across the globe. All products are developed and manufactured in-house, supported by regulatory documentation, application-specific consulting, and global technical support.